Mepolizumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2224 publications

Small airway dysfunction and associated clinical characteristics in severe asthma under omalizumab and mepolizumab treatment.

Small airway dysfunction and associated clinical characteristics in severe asthma under omalizumab and mepolizumab treatment.

Journal: Asian Pacific journal of allergy and immunology

Published: August 23, 2026

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

Journal: American journal of rhinology & allergy

Published: August 20, 2026

The effect of biologics on pulmonary function tests and small airways in patients with severe asthma: a real-life study.

The effect of biologics on pulmonary function tests and small airways in patients with severe asthma: a real-life study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: August 20, 2026

Outcomes of Biologic Switching in Chronic Rhinosinusitis With Nasal Polyps.

Outcomes of Biologic Switching in Chronic Rhinosinusitis With Nasal Polyps.

Journal: American journal of rhinology & allergy

Published: August 14, 2026

Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.

Three-year sustained remission with mepolizumab in a rare eosinophilic disease: idiopathic chronic eosinophilic pneumonia.

Journal: European clinical respiratory journal

Published: August 13, 2026

Effectiveness of mepolizumab in eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Effectiveness of mepolizumab in eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Journal: Rhinology

Published: August 11, 2026

Healthcare Utilization After Biologic Initiation for Chronic Rhinosinusitis.

Healthcare Utilization After Biologic Initiation for Chronic Rhinosinusitis.

Journal: American journal of rhinology & allergy

Published: August 05, 2026

Real-world disease burden, patient journey and treatment patterns in eosinophilic granulomatosis with polyangiitis in Europe and the USA.

Real-world disease burden, patient journey and treatment patterns in eosinophilic granulomatosis with polyangiitis in Europe and the USA.

Journal: EULAR rheumatology open

Published: August 01, 2026

A novel adjunct for COPD: Could it be type II inflammation?

A novel adjunct for COPD: Could it be type II inflammation?

Journal: The Nurse practitioner

Published: July 31, 2026

Characteristics of severe asthma patients with biologic treatment in the Swedish National Airway Register.

Characteristics of severe asthma patients with biologic treatment in the Swedish National Airway Register.

Journal: European clinical respiratory journal

Published: July 28, 2026

IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.

IL-5 biology and eosinophil regulation: Advances, resistance pathways and future directions.

Journal: Respiratory medicine

Published: July 20, 2026

Biologic Therapy Is Associated with Reduced Pleural-Line Thickness in Severe Asthma: A Prospective Transthoracic Ultrasound Study.

Biologic Therapy Is Associated with Reduced Pleural-Line Thickness in Severe Asthma: A Prospective Transthoracic Ultrasound Study.

Journal: Journal of clinical medicine

Published: July 12, 2026

Showing 1-12 of 2,224

Last Updated: 09/26/2026